Navigation Links
Sequenom Announces Global Certified Service Provider Program
Date:9/18/2013

SAN DIEGO, Sept. 18, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced a Certified Service Provider (CSP) program for the technical certification of selected laboratories offering research services using the Sequenom research-use-only MassARRAY® System. Certifications cover the major research applications of the MassARRAY System, including iPLEX® genotyping, OncoCarta™ somatic mutation profiling, ADME PGx, and EpiTyper® DNA methylation analysis.

"The use of the MassARRAY System in clinical and translational research continues to grow," said Michael Monko, Sequenom's Senior Vice President for Genetic Analysis. "Clinical and translational researchers require the greatest level of confidence in their data, and this program provides assurance in the quality of the work generated by our network of highly experienced certified providers."

The certifications have been awarded to the McGill University and Genome Quebec Innovation Centre in Montreal, Canada, Knight Diagnostic Laboratories at Oregon Health & Science University, and GeneWorks in Adelaide, Australia. Additional institutions have included The Clinical Genomics Centre in Toronto, Canada, Karolinska University Hospital in Sweden, NewGene in Newcastle, UK, DNA LandMarks (a plant and animal genomics company and subsidiary of BASF) based in Quebec, Canada, as well as several providers based in Asia.

"We are delighted to partner with Sequenom, and this certification confirms the high-quality standards we have i
'/>"/>

SOURCE Sequenom, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2012
2. Sequenom Completes International Distribution Agreements To Expand Access To MaterniT21 PLUS Prenatal Testing Service
3. Sequenom Welcomes Myla Lai-Goldman, M.D., To Board Of Directors
4. Sequenom Announces Exercise In Full Of Over-Allotment Option And Completion Of Offering Of $130 Million Of 5.00% Convertible Senior Notes
5. Sequenom CMMs MaterniT21 PLUS LDT Now Reporting On Gender-Specific Chromosomal Abnormalities
6. Sequenom, Inc. Announces Date Of Fourth Quarter And Full Year 2012 Financial Results And Conference Call
7. Sequenom Announces Participation At The Barclays Global Healthcare Conference
8. Sequenom, Inc. Reports Financial Results For The Fourth Quarter And Full Year Of 2012
9. Morning Research on Sequenom, Peregrine Pharma, Onyx Pharma, and Inovio Pharma
10. Sequenom Announces Participation At The Bank Of America Merrill Lynch Health Care Conference
11. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014  IRIDEX Corporation (NASDAQ: IRIX ... quarter 2014 financial results after the market closes on ... the release, the Company will host a conference call ... Time on Thursday, July 31, 2014 ... business developments. Interested parties may access the ...
(Date:7/24/2014)... and MENLO PARK, Calif. , July 24, ... ("DelMar" "the company") announced today that the company,s board of ... December 31 to June 30. Accordingly, DelMar will file a ... Jeffrey Bacha , president and CEO of DelMar ... step in achieving our goal of obtaining a senior exchange ...
(Date:7/24/2014)...  Kinex Pharmaceuticals announced the receipt of an allowance ... for the commencement of a Phase I clinical study ... to be allowed by the US FDA in the ... orally active and highly selective inhibitor of Src tyrosine ... of p53, G2/M arrest of proliferating cell populations and ...
Breaking Medicine Technology:DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 2DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4
... invivodata inc., the ... and services for global clinical research, today announced ... provide the EXAcerbations of Chronic pulmonary disease Tool ... is a Patient-Reported Outcome (PRO) measure for evaluating ...
... testing in humans watershed moment for unique malaria ... a move that highlights the strength of public-private ... company Sanaria Inc., with support from the PATH ... 1 clinical trial -- the first tests in ...
Cached Medicine Technology:invivodata Certified to Deliver EXACT in COPD Trials 2invivodata Certified to Deliver EXACT in COPD Trials 3Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin 2Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin 3Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin 4
(Date:7/24/2014)... (PRWEB) July 25, 2014 Voted one ... of the global clients, BellasDress focuses on providing its ... useful fashion information. Recently, the company has announced its ... in the new range is created according to the ... big discounts, up to 68% off. , As a ...
(Date:7/24/2014)... Triangle Park, NC (PRWEB) July 24, 2014 ... elderly, ethnic minorities, and low-income households are disproportionately ... and public food safety net in the United ... International. , Under Section 743 of the Consolidated ... U.S. Department of Agriculture's Food and Nutrition Service ...
(Date:7/24/2014)... Four Seasons Resort Maui at ... $3 million renovation of the famed Maile suite and ... just in time to welcome summer guests vacationing to ... from the internationally-acclaimed BraytonHughes Design Studios, San Francisco and ... and the largest in Hawaii—received a complete re-envisioning. No ...
(Date:7/24/2014)... Just as fitness and health professionals take ... financial and marketing strength to be important as well. ... next level by using the most powerful communication tools ... Call Tracking and SMS texting solutions . , ... are quickly become integral in marketing and communication methods ...
(Date:7/24/2014)... HealthDay Reporter THURSDAY, July 24, ... may be dead wrong, according to a small study that asked ... with 33 boys between the ages of 14 and 16, researchers ... for the closeness and trust. Very few boasted about sexual conquests ... with a girl. "In our culture, we have lots of ...
Breaking Medicine News(10 mins):Health News:BellasDress Helps Brides Get High End Wedding Dresses for Their Romantic Weddings 2Health News:Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs 2Health News:Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs 3Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 2Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 3Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 4Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 5Health News:Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st 2Health News:Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st 3Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 2Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 3
... Buffalo announced today a $10 million gift from Jeremy M. ... Institute, which will support research and clinical collaboration on the ... ... D. Jacobs, M.D., a world-renowned medical pioneer and the late ...
... 13 Elekta, a world-class leader in,advanced ... virtual patient clinic, enabling clinicians, patients and,the ... themselves with,Elekta,s products* and solutions and how ... clinic, available via http://www.elekta.com/evc , ...
... HILL, N.C., June 13 Long and costly ... to,maximize limited staff and resources to the development ... companies are integrating,commercial insights earlier and earlier into ... and target promising compounds, reduce development cycle,time, focus ...
... in diet and other factors , , FRIDAY, June 13 (HealthDay ... advice to people at high risk of heart disease effectively ... cholesterol and smoking. , "The results we see are very ... Dr. David Wood, a cardiology professor at Imperial College in ...
... Friday 13 June 2008: Rheumatoid arthritis (RA), ... should undergo compulsory cardiovascular (CV) risk management and ... the increased CV risk in inflammatory rheumatic disease ... Management in RA, recommended today at EULAR 2008, ...
... WASHINGTON, June 13 A new "hospital report,card" ... the Department,s,health care system high marks, with VA ... accepted by the health,care industry., "This report ... care VA,provides to our veterans," said Dr. James ...
Cached Medicine News:Health News:$10 million gift will retain and recruit world-class researchers to University at Buffalo 2Health News:$10 million gift will retain and recruit world-class researchers to University at Buffalo 3Health News:$10 million gift will retain and recruit world-class researchers to University at Buffalo 4Health News:Elekta Launches Web-based Virtual Clinic, Offers Better Understanding of Radiotherapy Solutions for the Treatment of Cancer 2Health News:Bio-Pharma Launch Value Maximized Through New Product Commercialization Excellence 2Health News:Lifestyle Counseling Reduces Heart Risk 2Health News:Lifestyle Counseling Reduces Heart Risk 3Health News:CV risk management should be mandatory in RA and other types of inflammatory rheumatic disease 2Health News:CV risk management should be mandatory in RA and other types of inflammatory rheumatic disease 3Health News:Health Care 'Report Card' Gives VA High Marks 2
... are individually adjusted for perfect focus where ... on paper. This, along with Keeler's wide ... that whatever the patient's pupil size, you ... of view. Lithium-ion technology provides a longer ...
... 200 ophthalmoscope, the world's ... ophthalmoscope. Heine's aspherical optical ... along with innovative design ... the Beta 200 the ...
... The Heine Beta 200S is ... with a combination of patented ... and a range of corrective ... dpt. in single diopter steps. ...
... The ophthalmoscope with superior aspherical optics. The ... means of the aspherical optical system avoids ... 200 allows you to view the whole ... even with a small pupil. Conventional ophthalmoscopes ...
Medicine Products: